Noom Launches New Tools to Tackle U.S. Diabetes Crisis

New updates have been reported about Noom (PC:NOOMM)

Noom, a leader in preventive health solutions, has unveiled two innovative offerings aimed at addressing the escalating diabetes crisis in the United States. The company has introduced a Diabetes Lifestyle Program tailored for employers and health plans, alongside a Glucose Forecasting tool available to both enterprise and select consumer members. These initiatives highlight Noom’s dedication to providing personalized, science-driven health solutions to combat type 2 diabetes, a rapidly growing and costly chronic condition. The Diabetes Lifestyle Program, which combines personalized coaching, nutrition guidance, and smart tracking tools, has shown significant health improvements in participants within three months. This program not only empowers individuals but also offers measurable engagement and cost-saving benefits to employers and payers.

Noom’s Glucose Forecasting tool represents a breakthrough in diabetes management by predicting the impact of meals on future blood glucose levels without the need for continuous glucose monitors or additional hardware. By leveraging advanced models based on demographics such as age, sex, BMI, and metabolic status, this tool provides predictive insights that help individuals make informed decisions to optimize their metabolic health. This proactive approach aims to prevent the progression of prediabetes and reduce long-term complications, ultimately decreasing healthcare costs for employers and payers. Cody Fair, Noom’s Chief Commercial Officer, emphasized the importance of early intervention and the role of behavioral science in managing diabetes effectively. These new offerings align with Noom’s mission to make health insights widely accessible and promote sustainable behavior change, supporting a future of improved longevity for all.